Skip to main content
Clinical Trials/NCT01603901
NCT01603901UnknownNot Applicable

Regulated Negative Pressure-Assisted Wound Therapy Device

Hillel Yaffe Medical Center2 sites in 1 country10 target enrollmentStarted: June 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
10
Locations
2
Primary Endpoint
Efficacy

Study Overview

Brief Summary

Regulated negative pressure-assisted wound therapy (RNPT) is regarded as a gold standard technology for treatment of various chronic and acute wounds. The investigators plan to evaluate the efficacy and ease of use of this device.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Chronic or acute wounds

Exclusion Criteria

  • Uncontrolled bleeding
  • Neoplasms in wound
  • Exposed blood vessels
  • Exposed internal organs

Outcomes

Primary Outcomes

Efficacy

Time Frame: Ten days

Measurement of change in wound size

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials